Risk factors for pituitary tumors: A case-control study

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 5, 2009, Pages 1492-1500

  Schoemaker, Minouk J ^a   Swerdlow, Anthony J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE;

ADULT; ARTICLE; CHILDBIRTH; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HAY FEVER; HUMAN; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MENOPAUSE; MORBIDITY; NULLIPARA; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ENGLAND; FEMALE; HUMANS; INCIDENCE; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MALE; MATERNAL AGE; MENOPAUSE; MIDDLE AGED; PITUITARY NEOPLASMS; RISK FACTORS;

EID: 66549116192     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0657     Document Type: Article

References (34)

1. DeLellis R, LLoyd R, Heitz P, Eng C. Pathology and genetics of tumours of endocrine origin. World Health Organization Classification of Tumours. Lyon: IARC Press; 2004. p. 320.
2. Asa SL, Ezzat S. The pathogenesis of pituitary tumours. Nat Rev Cancer 2002;2:836-849 (Pubitemid 37328902)
3. Vance ML. Treatment of patients with a pituitary adenoma: one clinician's experience. Neurosurg Focus 2004;16:E1.
4. Kameya T, Tsukada T, Yamaguchi K. Recent advances in MEN1 gene study for pituitary tumor pathogenesis. Front Horm Res 2004;32:265-291
5. Beckers A, Daly AF. The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 2007;157:371-382 (Pubitemid 350018439)
6. Vierimaa O, Georgitsi M, Lehtonen R, et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006;312:1228-1230 (Pubitemid 43801151)
7. Coulam CB, Annegers JF, Abboud CF, Laws ER, Jr., Kurland LT. Pituitary adenoma and oral contraceptives: a case-control study. Fertil Steril 1979;31:25-28 (Pubitemid 9218454)
8. Teperman L, Futterweit W, Zappula R, Malis LI. Oral contraceptive history as a risk indicator in patients with pituitary tumors with hyperprolactinemia: a case comparison study of twenty patients. Neurosurgery 1980;7:571-573 (Pubitemid 11210053)
9. Wingrave SJ, Kay CR, Vessey MP. Oral contraceptives and pituitary adenomas. Br Med J 1980;280:685-686 (Pubitemid 10184302)
10. Jones JR, Kemmann E, Norwood PK. Oral contraceptive exposure of amenorrheic women with and without prolactinomas. Int J Gynaecol Obstet 1981;19:381-387 (Pubitemid 11028054)
11. Maheux R, Jenicek M, Cleroux R, et al. Oral contraceptives and prolactinomas: a case-control study. Am J Obstet Gynecol 1982;143:134-138
12. Shy KK, McTiernan AM, Daling JR, Weiss NS. Oral contraceptive use and the occurrence of pituitary prolactinoma. JAMA 1983;249:2204-2207
13. Anonymous. Pituitary adenomas and oral contraceptives: a multicenter case-control study. Fertil Steril 1983;39:753-760
14. Coogan PF, Baron JA, Lambe M. Parity and pituitary adenoma risk. J Natl Cancer Inst 1995;87:1410-1411
15. Hemminki K, Chen B. Are twins at risk of cancer: results from the Swedish family-cancer database. Twin Res Hum Genet 2005;8:509-514 (Pubitemid 41499492)
16. Hemminki K, Forsti A, Ji J. Incidence and familial risks in pituitary adenoma and associated tumors. Endocr Relat Cancer 2007;14:103-109 (Pubitemid 47521726)
17. Hemminki K, Jiang Y. Second primary neoplasms after 19281 endocrine gland tumours: aetiological links? Eur J Cancer 2001;37:1886-1894
18. Bondy ML, Scheurer ME, Malmer B, et al. Brain Tumor Epidemiology Consortium. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008;113(7 Suppl):1953-1968
19. Cardis E, Richardson L, Deltour I, et al. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol 2007;22:647-664 (Pubitemid 47402436)
20. WHO. International Statistical Classification of diseases and related health problems, 10th revision. Geneva: World Health Organization; 1992.
21. OPCS. Morbidity Statistics from General Practice; Fourth national study 1991-1992. London: HMSO; 1995.
22. Statistics Netherlands. Blaise. Voorburg/Heerlen: Statistics Netherlands; 2003.
23. Schoemaker MJ, Swerdlow AJ. Risk of pituitary tumors in cellular phone users; a case-control study. Epidemiology 2009; 20. Published online March 9, 2009.
24. Townsend P, Phillimore P, Beattie A. Health and Deprivation: Inequality and the North. New York: Croom Helm; 1988.
25. StataCorp. Stata Statistical Software: Release 9.0. College Station, Texas: Stata Corporation; 2006.
26. Preston DL, Ron E, Yonehara S, et al. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 2002;94:1555-1563 (Pubitemid 35277279)
27. Gold EB. Epidemiology of pituitary adenomas. Epidemiol Rev 1981;3:163-183 (Pubitemid 12164158)
28. Stefaneanu L. Experimental models of pituitary tumorigenesis. In: Thapar K, et al., editors. Diagnosis and management of pituitary tumours. Totowa (NJ): Humana Press; 2001. p. 81-90.
29. Christin-Maitre S, Delemer B, Touraine P, Young J. Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy. Ann Endocrinol (Paris) 2007;68:106-112
30. Linos E, Raine T, Alonso A, Michaud D. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 2007;99:1544-1550
31. Nakachi K, Hayashi T, Imai K, Kusunoki Y. Perspectives on cancer immuno-epidemiology. Cancer Sci 2004;95:921-929 (Pubitemid 40089582)
32. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 2006;91:4769-4775 (Pubitemid 44917305)
33. Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: a systematic review. Cancer 2004;101:613-619 (Pubitemid 38970613)
34. Original Data Depositor-2001 Census. Census Area Statistics (Scotland) and Census Area Statistics (England & Wales) [computer file]. 2001. ESRC/JISC Census Programme, Census Dissemination Unit, MIMAS (University of Manchester)/Census Interaction Data Service (University of Leeds).